Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease

Tau Aggregates: Toxic, Inert, or Protective Species?

(2017) Alexis Bretteville et al.   JOURNAL OF ALZHEIMERS DISEASE

Mutant huntingtin is present in neuronal grafts in huntington disease patients

(2014) Francesca Cicchetti et al.   ANNALS OF NEUROLOGY

Mutant huntingtin alters Tau phosphorylation and subcellular distribution

(2014) David Blum et al.   HUMAN MOLECULAR GENETICS

Huntington's disease is a four-repeat tauopathy with tau nuclear rods

(2014) Marta Fernández-Nogales et al.   NATURE MEDICINE

Specificity of Anti-Tau Antibodies when Analyzing Mice Models of Alzheimer's Disease: Problems and Solutions

(2014) Franck R. Petry et al.   PLoS One

Deregulation of Protein Phosphatase 2A and Hyperphosphorylation of   Protein Following Onset of Diabetes in NOD Mice

(2012) M.-A. Papon et al.   DIABETES

Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6/2 mouse model of Huntington's disease

(2012) P. Samadi et al.   GENES BRAIN AND BEHAVIOR

Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models

(2012) Arnaud Tauffenberger et al.   HUMAN MOLECULAR GENETICS

Tonic mGluR5/CB1-dependent suppression of inhibition as a pathophysiological hallmark in the striatum of mice carrying a mutant form of huntingtin

(2012) Anton Dvorzhak et al.   JOURNAL OF PHYSIOLOGY-LONDON

Dimethyl Sulfoxide Induces Both Direct and Indirect Tau Hyperphosphorylation

(2012) Carl Julien et al.   PLoS One

Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington’s Disease: zQ175

(2012) Liliana B. Menalled et al.   PLoS One

Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington's Disease

(2012) Taneli Heikkinen et al.   PLoS One

Accelerated Human Mutant Tau Aggregation by Knocking Out Murine Tau in a Transgenic Mouse Model

(2011) Kunie Ando et al.   AMERICAN JOURNAL OF PATHOLOGY

MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy

(2011) Pascal Y. Smith et al.   HUMAN MOLECULAR GENETICS

Increased levels of total tau protein in the cerebrospinal fluid in Huntington’s disease

(2011) Radu Constantinescu et al.   PARKINSONISM & RELATED DISORDERS

Somatostatin Receptor 1 and 5 Double Knockout Mice Mimic Neurochemical Changes of Huntington's Disease Transgenic Mice

(2011) Padmesh S. Rajput et al.   PLoS One

Nuclear Tau, a Key Player in Neuronal DNA Protection

(2010) Audrey Sultan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Neuroprotective Effects of Ginsenosides on Calcineurin Activity and Tau Phosphorylation in SY5Y Cells

(2009) Ling-Hui Tu et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

The Novel Calcineurin Inhibitor CN585 Has Potent Immunosuppressive Properties in Stimulated Human T Cells

(2009) Frank Erdmann et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Association of corticobasal degeneration and Huntington's disease: Can Tau aggregates protect Huntingtin toxicity?

(2009) Dominique Caparros-Lefebvre et al.   MOVEMENT DISORDERS

Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: Role in excitotoxicity

(2009) Xavier Xifró et al.   NEUROBIOLOGY OF DISEASE

Anesthesia-Induced Hyperphosphorylation Detaches 3-Repeat Tau from Microtubules without Affecting Their Stability In Vivo

(2008) E. Planel et al.   JOURNAL OF NEUROSCIENCE